Milcah Grace Caculitan
Family · Winter Haven, FLNPI 1306279807
Payments from drug & device makers
Across 245 payments — averaging $24.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$629
- AbbVie$606
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$383
- Boehringer Ingelheim$342
- Merck$339
- AstraZeneca$326
- plus $3K from 30 others
What the payments were for
- Food & beverage$5,888100%
- Education$210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 28 | $629 |
| AbbVie(2 entities) | 37 | $606 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 17 | $383 |
| Boehringer Ingelheim | 9 | $342 |
| Merck | 12 | $339 |
| AstraZeneca(2 entities) | 8 | $326 |
| Cvrx, Inc. | 3 | $310 |
| Lexicon Pharmaceuticals, Inc. | 8 | $287 |
| Novartis | 16 | $274 |
| Biogen | 10 | $249 |
| Pfizer | 10 | $247 |
| Alnylam Pharmaceuticals Inc. | 7 | $220 |
| Sanofi | 11 | $211 |
| Amneal Pharmaceuticals LLC | 9 | $174 |
| Amgen | 8 | $156 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $132 |
| Johnson & Johnson | 6 | $116 |
| Novo Nordisk | 2 | $114 |
| Boston Scientific | 4 | $108 |
| Biohaven Pharmaceuticals, Inc. | 5 | $87 |
| Scpharmaceuticals Inc. | 3 | $72 |
| EMD Serono, Inc. | 2 | $53 |
| Abbott | 2 | $53 |
| Lilly USA, LLC | 3 | $52 |
| Baxter Healthcare | 3 | $51 |
| Neurelis, Inc. | 3 | $49 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Eisai Inc. | 2 | $40 |
| UCB, Inc. | 1 | $38 |
| Hikma Pharmaceuticals USA | 2 | $36 |
| Medtronic | 1 | $25 |
| Sunovion Pharmaceuticals Inc. | 1 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Philips North America LLC | 1 | $18 |
| Shockwave Medical, Inc | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Barostim Neo System$278
- JARDIANCE$243
- CAMZYOS$130
- AIRSUPRA$121
- AMVUTTRA$110
How this compares
$5,909 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 204 | $156,314 |
| JardianceEmpagliflozin | 191 | $136,036 |
| EliquisApixaban | 133 | $105,941 |
| FarxigaDapagliflozin Propanediol | 58 | $38,373 |
| XareltoRivaroxaban | 50 | $35,476 |
| Ranolazine ErRanolazine | 12 | $1,209 |
| Metoprolol Succinate | 110 | $918 |
| Midodrine Hcl | 16 | $672 |
| Spironolactone | 81 | $495 |
| Carvedilol | 77 | $375 |
| Losartan Potassium | 61 | $308 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 11 | $303 |
| Hydralazine Hcl | 41 | $281 |
| ClopidogrelClopidogrel Bisulfate | 26 | $253 |
| SotalolSotalol Hcl | 13 | $226 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $274 | $156,314204 claims |
| Boehringer IngelheimJardiance | $342 | $136,036191 claims |
| PfizerEliquis | $247 | $105,941133 claims |
| AstraZenecaFarxiga | $326 | $38,37358 claims |
| Johnson & JohnsonXarelto | $116 | $35,47650 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 14,618 family providers in Florida.
Other family in Winter Haven
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.